Preclinical studies of BB-1701, a HER2-targeting eribulin-containing ADC with potent bystander effect and ICD activity
Yang Wang(Hangzhou Wanxiang Polytechnic), Yuhong Zhou(Sun Yat-sen University)
Cited by 11
Related Papers
CD103<sup>+</sup>CD8<sup>+</sup> tissue‐resident memory T lymphocytes of melanoma boost anti‐tumour immunity and predict immunotherapy outcomes
|Clinical and Translational Medicine|2025|5
MDM2 inhibitors in sarcomas: results and next steps
|Current Opinion in Oncology|2025|2